The cardiotoxic and cytotoxic effects of the Cu(II)-doxorubicin (DXR) complex [Cu(DXR)]n are compared with those of the parent drug. It is shown that 10-4M [Cu(DXR)]n has no depressant effects on isolated rat atria, in contrast with an equimolar concentration of the parent drug. No differences were found between the cytotoxic activities of the Cu(II) complex and free DXR on B16 melanoma and HeLa cells. A reduced penetration of the polymeric [Cu(DXR)]n into the myocardial cells as compared with the free drug was invoked to account for the absence of cardiotoxicity of the DXR complex. On the other hand, the observation that copper-complexation does not affect the cytotoxicity of the drug suggests that extracellular as well as intracellular mechanisms may be involved in the development of its antitumor activity. © 1990 Springer-Verlag.

Monti, E., Paracchini, L., Piccinini, F., Malatesta, V., Morazzoni, F., Supino, R. (1990). Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 25(5), 333-336 [10.1007/BF00686232].

Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate

MORAZZONI, FRANCA;
1990

Abstract

The cardiotoxic and cytotoxic effects of the Cu(II)-doxorubicin (DXR) complex [Cu(DXR)]n are compared with those of the parent drug. It is shown that 10-4M [Cu(DXR)]n has no depressant effects on isolated rat atria, in contrast with an equimolar concentration of the parent drug. No differences were found between the cytotoxic activities of the Cu(II) complex and free DXR on B16 melanoma and HeLa cells. A reduced penetration of the polymeric [Cu(DXR)]n into the myocardial cells as compared with the free drug was invoked to account for the absence of cardiotoxicity of the DXR complex. On the other hand, the observation that copper-complexation does not affect the cytotoxicity of the drug suggests that extracellular as well as intracellular mechanisms may be involved in the development of its antitumor activity. © 1990 Springer-Verlag.
Articolo in rivista - Articolo scientifico
doxorubicin, antitumor, cardiotoxicity, copper, EPRch
English
1990
25
5
333
336
none
Monti, E., Paracchini, L., Piccinini, F., Malatesta, V., Morazzoni, F., Supino, R. (1990). Cardiotoxicity and antitumor activity of a copper(II)-doxorubicin chelate. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 25(5), 333-336 [10.1007/BF00686232].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/32229
Citazioni
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 20
Social impact